NMS-1286937

· Nerviano Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NMS-1286937, covering 2012-09-07 to 2012-09-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors [Phase 1]